Investigating the cardiac pathology of SCO2‐mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell–derived cardiomyocytes

Mutations in SCO2 are among the most common causes of COX deficiency, resulting in reduced mitochondrial oxidative ATP production capacity, often leading to hypertrophic cardiomyopathy (HCM). To date, none of the recent pertaining reports provide deep understanding of the SCO2 disease pathophysiolog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cell Mol Med
Autores principales: Hallas, Tova, Eisen, Binyamin, Shemer, Yuval, Ben Jehuda, Ronen, Mekies, Lucy N., Naor, Shulamit, Schick, Revital, Eliyahu, Sivan, Reiter, Irina, Vlodavsky, Eugene, Katz, Yeshayahu (Shai), Õunap, Katrin, Lorber, Avraham, Rodenburg, Richard, Mandel, Hanna, Gherghiceanu, Mihaela, Binah, Ofer
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783844/
https://ncbi.nlm.nih.gov/pubmed/29193756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13392
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares